Status:
UNKNOWN
Assessment of the Psychological Impact of the COVID19 (SARS-CoV-2) Pandemic on Patients With Chronic Inflammatory Rheumatism
Lead Sponsor:
University Hospital, Limoges
Conditions:
Rheumatism
Eligibility:
All Genders
18+ years
Brief Summary
Patients with chronic inflammatory rheumatism (RIC) or autoimmune diseases, rheumatoid arthritis and spondyloarthritis, are regularly monitored in consultation as part of a "treat to target" strategy ...
Eligibility Criteria
Inclusion
- All patients with chronic inflammatory rheumatism followed in the rheumatology department of the CHU de Limoges.
Exclusion
- Patients who object to the use of their data.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
950 Patients enrolled
Trial Details
Trial ID
NCT04723407
Start Date
February 1 2021
End Date
March 1 2022
Last Update
January 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Département de Rhumatologie
Limoges, France